Grupo Interdisciplinar en Tecnología Farmacéutica, Inmunobiología parasitaria y Parasitosis Hídricas
PARAQUASIL
![Foto de Grupo Interdisciplinar en Tecnología Farmacéutica, Inmunobiología parasitaria y Parasitosis Hídricas](/img/grupo.png)
![Foto de Instituto de Investigación Sanitaria de Santiago de Compostela](/img/noimage_org.png)
Instituto de Investigación Sanitaria de Santiago de Compostela
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (36)
2024
-
Development of inert coatings to prevent drug retention in 3D-printed diffusion cells
International Journal of Pharmaceutics, Vol. 659
-
Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions
International Journal of Molecular Sciences, Vol. 25, Núm. 6
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
-
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
Pharmaceutics, Vol. 16, Núm. 1
-
The Integration of Advanced Drug Delivery Systems into Conventional Adjuvant Therapies for Peri-Implantitis Treatment
Pharmaceutics, Vol. 16, Núm. 6
2023
-
Biomedical Applications of Lactoferrin on the Ocular Surface
Pharmaceutics, Vol. 15, Núm. 3
-
Bringing lipidic lyotropic liquid crystal technology into biomedicine
Trends in Pharmacological Sciences
-
Compression pressure-induced synergy in xanthan and locust bean gum hydrogels. Effect in drug delivery
Journal of Drug Delivery Science and Technology, Vol. 89
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
Pharmaceutics, Vol. 15, Núm. 11
-
Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial
Pharmaceutics, Vol. 15, Núm. 2
-
Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Infliximab microencapsulation: an innovative approach for intra-articular administration of biologics in the management of rheumatoid arthritis—in vitro evaluation
Drug Delivery and Translational Research, Vol. 13, Núm. 12, pp. 3030-3058
-
Intravitreal implants manufactured by supercritical foaming for treating retinal diseases
Journal of Controlled Release, Vol. 362, pp. 342-355
-
Lipidic lyotropic liquid crystals: Insights on biomedical applications
Advances in Colloid and Interface Science, Vol. 313
2022
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics
Acta Pharmaceutica Sinica B, Vol. 12, Núm. 2, pp. 621-636
-
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
International Journal of Pharmaceutics, Vol. 627
-
Stability of insulin eye drops in the treatment of refractory corneal ulcers
Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 335-339
2021
-
3D printing of pharmaceutical products
Additive Manufacturing (Elsevier), pp. 569-597
-
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
Pharmaceutics, Vol. 13, Núm. 10